Tuberous Sclerosis Complex (TSC) is considered a rare genetic disorder, but it's more common than once thought, affecting roughly 1 in 6,000 to 10,000 live births, or about 1 million people worldwide, with many cases mild and undetected. While traditionally seen as very rare, improved diagnostics mean more people are diagnosed, revealing benign tumors and neurological issues like epilepsy and autism in multiple organs, though severity varies greatly.
What is the normal life expectancy of a person with TSC? Most people will have a normal life span.
Patients' age at diagnosis ranged from birth to 73 years. The average age at diagnosis was 7.5 years, and median was 1 year. Patients were most likely to be diagnosed during the first 6 months of life.
Growths in the brain may be linked with seizures. A seizure is often the first symptom of tuberous sclerosis. In small children, a common type of seizure called infantile spasm involves stiffening of the arms and legs and arching the back and head. Problems in thinking, reasoning and learning.
Frequently Asked Questions. How common is tuberous sclerosis complex? It is estimated that about 50,000 people in the United States and 1 million worldwide have TSC. About one in 6,000 children are born with the disease each year.
Around 90% of autism cases are attributed to genetic factors, meaning autism is highly heritable, with many different genes contributing, rather than a single cause, often interacting with environmental influences during early brain development, though specific environmental factors don't cause it but can increase risk. Twin studies show strong genetic links, with concordance rates between 60-90% in identical twins, and research points to complex interactions of many genes and prenatal/perinatal factors.
In about one-third of cases, an affected person inherits an altered TSC1 or TSC2 gene from a parent who has the disorder . The remaining two-thirds of people with tuberous sclerosis complex are born with new variants in the TSC1 or TSC2 gene.
About 40% of cases are due to genetic mutations passed down from a family member. The remaining 60% of TSC patients have a new genetic mutation that causes the disorder. People from all ethnic groups develop tuberous sclerosis complex. Both males and females are equally affected.
Most cases of TSC are sporadic (developing on their own) due to new, spontaneous variations in TSC1 or TSC2—meaning neither parent has the disorder or the genetic variation(s). Some cases of TSC are inherited, meaning the mutated gene is passed down from a parent to their child.
Tuberous sclerosis complex (TSC) is a known genetic disorder with behavioral manifestations including autism. A literature review of these two disorders substantiates a significant association of autism and TSC with 17-58% of TSC subjects manifesting autism and 0.4-3% of autistic subjects having TSC.
Symptoms of multiple sclerosis (MS)
Some of the most common symptoms include: feeling extremely tired (fatigue) problems with your eyes or your vision, such as blurred vision or eye pain. numbness or a tingling feeling in different parts of the body.
This condition, sometimes known simply as tuberous sclerosis, can affect people in many ways. People with less severe cases may see very few effects and have a normal lifespan. Severe cases can lead to serious complications. TSC is a disease that may progress slowly.
Tuberous Sclerosis Complex (TSC) is a lifelong condition that may require long-term care in different forms, depending on the severity and impact of the condition on an individual. There is currently no cure for TSC.
TB disease is usually treated with antibiotics and can be fatal without treatment. In certain countries, the Bacille Calmette-Guérin (BCG) vaccine is given to babies or small children to prevent TB. The vaccine prevents deaths from TB and protects children from serious forms of TB.
12, 13 In our series, only one patient with TSC had an aneurysm of the ascending thoracic aorta, and its rupture and the resultant hemothorax caused death. In our series, the most common cause of death was renal disease in the form of angiomyolipomas,14 cysts, or both. Angiomyolipomas are more common than renal cysts.
In 2020, everolimus was approved by the FDA for the treatment of inoperable subependymal giant cell astrocytomas (SEGAs) in patients with TSC. It is now approved in many countries for treating renal angiomyolipomas and partial-onset epilepsy associated with TSC, in addition to SEGAs [40,70].
The causes of tic disorders and Tourette syndrome are not completely understood, but it has been found that Tourette syndrome often runs in families. Nearly 70-80 percent of patients with Tourette syndrome have a genetic predisposition, making it one of the most inheritable childhood-onset neuropsychiatric disorders.
If a parent lives with TSC, there is a 50% chance that their child will also inherit the condition. Therefore, many people who have parents, siblings or children who live with TSC, have an assessment or genetic test to see if they also have TSC.
About 45 to 60 percent of people with TSC have intellectual disabilities including hyperactivity, developmental delay, autism or aggression. 13. Patient organisation-funded research led to the identification of two genes that cause TSC; these genes are called TSC1 and TSC2.
Disease Overview
Tuberous sclerosis is a rare genetic multisystem disorder that is typically apparent shortly after birth. The disorder can cause a wide range of potential signs and symptoms and is associated with the formation of benign (non-cancerous) tumors in various organ systems of the body.
There are no known cases of an individual having a disease-causing variant in both genes, and TSC does not skip a generation. It is possible for a member of the family to have such a mild case of TSC as to seem unaffected.
Intellectual disability was present in 57% of individuals with tuberous sclerosis complex (TSC). Those with TSC without intellectual disability had significantly lower mean IQ compared to unaffected siblings.
Tuberous sclerosis complex (TSC) is a genetic disorder with a high prevalence of autism spectrum disorder (ASD). Tremendous progress in understanding the pathogenesis of TSC has been made in recent years, along with initial trials of medical treatment aimed specifically at the underlying mechanism of the disorder.
Mean life expectancy was 66.2 years compared to an average of 81.8 in the general population. In the seven studies that reported specific causes of mortality in the general TSC population, 6/7 studies (85 %) had renal or central nervous system disease as the most common cause of mortality.
Dysregulated behaviors, including aggression, temper tantrums, and self-injury, represent the greatest concerns and burdens to families who live with TSC. These behaviors are therefore a common reason for referral to specialist services.